CytomX Therapeutics Competitors and Similar CompaniesClear all
Stingray Therapeutics's competitors and similar companies include Forbius, SQZ Biotech and Ablynx.
 Stingray Therapeutics Stingray Therapeutics is a company that specializes in immunotherapy to fight cancer. |  Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. |  SQZ Biotech SQZ Biotechnologies is a company that develops cell therapies for patients with cancer and infectious diseases. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | |
Founding Date | Founding Date 2018 | Founding Date 2011 | Founding Date 2013 | Founding Date 2001 |
Type | Type Private | Type Subsidiary | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Houston, US HQ | Locations Austin, US HQ Montréal, CA | Locations Watertown, US HQ | Locations Gent, BE HQ |
Employees | Employees 6 | Employees 9 | Employees 5353% decrease | Employees 156 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $21.5m (FY, 2022) | Revenue (est.) €85.2m (FY, 2016) |
Net income | Net income N/A | Net income N/A | Net income ($79.5m) (FY, 2022) | Net income (€1.1m) (FY, 2016) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 233.4m | Total funding raised $ 498.8m |
For sources of this data, please see the company profile
View Company Profiles
Forbius
HQ
Austin, US
Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
View companySQZ Biotech
HQ
Watertown, US
Employees
53
SQZ Biotechnologies is a company that develops cell therapies for patients with cancer and infectious diseases.
View companyAblynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company